28th Annual North American Cystic Fibrosis Conference

W24: NT: Innovative Approaches to CF Outcomes & Therapies

Oct 11, 2014 2:30pm ‐ Oct 11, 2014 4:15pm

Standard: $49.99

Description

In this session the most recent data of clinical trials evaluating CFTR mutation-specific pharmacological therapeutics will be presented. Also, promising novel molecular therapies targeting CFTR mutations will be discussed.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content